(Press-News.org) Patients with diabetes have an increased risk of complications after stent implantation, according to a study from Karolinska Institutet in Sweden published in Diabetes Care. The study, which includes over 160,000 patients, emphasises the importance of tailoring treatment strategies for this specific patient group.
Researchers have conducted a comprehensive study to investigate the risk of stent complications in patients with diabetes. The study consists of data from over 160,000 patients who received drug-eluting stents (small tubes placed in the coronary arteries of the heart that slowly release drugs to reduce the risk of the vessel becoming blocked again) between 2010 and 2020. The patients were divided into three groups: type 1 diabetes, type 2 diabetes, and patients without diabetes.
The results show that patients with type 1 diabetes have more than twice the risk of stent complications compared to patients without diabetes. For patients with type 2 diabetes, the risk is also elevated, but not as significantly. Complications include both narrowing of the artery in the stent and blood clots in the stent.
“Our results show that people with diabetes, especially type 1 diabetes, have a much higher risk of stent complications. Therefore, it is important to carefully consider how we treat these patients,” says first author Irene Santos-Pardo, researcher at the Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet.
The study also shows that the risk of stent complications is highest during the first few months after stent implantation. During the first month, the incidence of stent complications was 9.27 per 100 person-years for patients with type 1 diabetes, compared with 4.34 for patients without diabetes. After six months, the risk decreased but remained higher for patients with diabetes.
“We need to continue to investigate how we can improve treatment for patients with diabetes who undergo stent implantation. Our results indicate that there is a need to adapt treatment and follow-up for them,” says last author Thomas Nyström, professor at the Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet.
The study is a collaboration between researchers at Karolinska Institutet and the Germans Trias i Pujol Institute in Barcelona. It has been funded by, among others, the Swedish Heart-Lung Foundation and Region Stockholm. The researchers report no conflicts of interest.
Publication: “Coronary stent failure in patients with diabetes: A nationwide observational study from SWEDEHEART”, Irene Santos-Pardo, Mikael Andersson Franko, Robin Hofmann, Thomas Nyström, Diabetes Care, online 27 November 2025, doi: 10.2337/dc25-1624.
END
Individuals with diabetes are more likely to suffer complications after stent surgery
2025-11-27
ELSE PRESS RELEASES FROM THIS DATE:
Polyphenol-rich diets linked to better long-term heart health
2025-11-27
People who regularly consume polyphenol-rich foods and drinks, such as tea, coffee, berries, cocoa, nuts, whole grains and olive oil, may have better long-term heart health.
The research, led by King’s College London, found that those with higher adherence to polyphenol-rich dietary patterns had lower predicted cardiovascular disease (CVD) risk.
Polyphenols are natural compounds found in plants that are linked to various health benefits, including improved heart, brain, and gut health.
The study, ...
Tai chi as good as talking therapy for managing chronic insomnia
2025-11-27
Tai chi, a form of mind-body exercise widely practiced in Chinese communities, has similar benefits to talking therapy for middle aged and older people with chronic insomnia, finds a trial from Hong Kong published by The BMJ today.
These results support the use of tai chi for the long term management of chronic insomnia in middle-aged and older adults, say the researchers.
Chronic insomnia is one of the most common sleep disorders in middle aged and older adults and has been linked to increased risks of cardiovascular ...
Monthly injection helps severe asthma patients safely stop or reduce daily steroids
2025-11-27
A monthly injection has helped 90% of severe asthma patients reduce daily steroid tablets, which are associated with long-term side effects.
More than half of the participants who had received the injection were able to stop their daily steroid tablets entirely, without any impact on their symptoms.
The clinical trial led by a King’s College London academic followed patients who had been injected with tezepelumab every four weeks for a year. Tezepelumab is a type of antibody which targets parts of the immune system, reducing lung inflammation.
Treatment with tezepelumab was also shown to significantly improve asthma symptoms, lung function, and overall quality of life. During ...
The Lancet Respiratory Medicine: Monthly injection may help severe asthma patients safely reduce or stop daily oral steroid use
2025-11-27
A monthly injection for managing severe asthma could help patients safely reduce or even discontinue daily steroid medications, according to a new phase 3b clinical trial published in The Lancet Respiratory Medicine journal.
Oral corticosteroids (OCS) are powerful medications that help control airway inflammation and asthma symptoms. In the most severe asthma patients, OCS are needed daily. However, long-term use can lead to serious health problems, including osteoporosis, diabetes, and increased vulnerability to infections.
The ...
Largest study reveals best treatment options for ADHD
2025-11-27
The most comprehensive review to date of ADHD treatments has found that medication for children and adults, and cognitive behavioural therapy for adults, remain the most effective approaches, backed by the strongest short-term trial evidence.
Researchers led by the Université Paris Nanterre (France), Institut Robert-Debré du Cerveau de l'Enfant (France), and the University of Southampton (UK) analysed over 200 meta-analyses covering different treatment types, participant groups, and clinical outcomes in a study published today [27 November 2027] in The BMJ.
The research was funded by public and peer-reviewed research ...
Tsunami from massive Kamchatka earthquake captured by satellite
2025-11-26
A satellite deployed to measure ocean surface heights was up to the challenge when a massive earthquake off the Kamchatka Peninsula triggered a Pacific-wide tsunami in late July.
The Surface Water Ocean Topography or SWOT satellite captured the first high-resolution spaceborne track of a great subduction zone tsunami, researchers report in The Seismic Record.
The track shows an unexpectedly complex pattern of waves dispersing and scattering across the ocean basin, one that could help tsunami scientists better understand how these events propagate and how they could threaten coastal communities.
Angel Ruiz-Angulo at the University of Iceland and ...
Hidden dangers in 'acid rain' soils
2025-11-26
Acid rain from fossil fuel pollution may be quietly training soil bacteria to become longer-lived, more transmissible, and more deadly, according to a new study in the journal New Contaminants that tracks how a notorious foodborne pathogen rapidly evolved under simulated acid deposition.
Acid deposition from burning coal, oil, and other fossil fuels has long been known to damage forests, lakes, and crops, but its impact on disease-causing microbes in soil has been largely overlooked. The new research shows that acid rain can destabilize the native soil microbiome in ways that make it easier for the pathogen Escherichia coli O157:H7 to invade and persist. In global soil metagenomic ...
Drug developed for inherited bleeding disorder shows promising trial results
2025-11-26
Hereditary hemorrhagic telangiectasia (HHT) is the second most common inherited bleeding disorder worldwide, affecting 1 in 3,800 persons. HHT’s hallmark symptom is chronic nosebleeds, which often occur alongside other internal bleeding and vascular malformations that impact quality of life and longevity. A new study from Mass General Brigham tested the safety and efficacy of engasertib, a drug specifically designed to target the condition. This 75-participant, double-blind, placebo-controlled trial found engasertib ...
New scan could help millions with hard-to-treat high blood pressure
2025-11-26
A speedy new scan could improve how millions of people with high blood pressure are treated, suggests a new study led by UCL (University College London) researchers.
About a quarter of people with high blood pressure have been estimated to have a problem with their adrenal glands producing too much of the hormone aldosterone, which regulates levels of salt in the body.
This problem is often missed, as the path to diagnosis is complex, involving multiple tests and, to guide treatment, an invasive procedure that is not always reliable.
The new 10-minute scan, developed at UCL and described in a research letter in the New England Journal ...
9th IOF Asia-Pacific Bone Health Conference set to open in Tokyo
2025-11-26
The International Osteoporosis Foundation (IOF) announces that the 9th IOF Asia-Pacific Bone Health Conference will officially begin in just three weeks, taking place from December 11–13, 2025, in Tokyo, Japan.
As the Asia-Pacific region faces a rapidly growing burden of osteoporosis and fracture-related health challenges, this major scientific congress will bring together healthcare professionals, researchers, and policymakers to exchange knowledge and shape the future of bone health across the ...